Back
DexCom, Inc. (DXCM)
Health CareDXCM · NASDAQ NMS - GLOBAL MARKET · USD
New to investing? How to read this page →$74.06
+0.67%Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for education and research only — not financial advice.
Key metrics
EPS
$2.06
ROE
35.6%
Gross margin
61.5%
Debt/Equity
0.47x
Revenue growth
15.0%
DexCom, Inc. — company intelligence
Earnings surprises
Q1 2026$0.56 vs $0.48 est+17.0%
Q4 2025$0.45 vs $0.66 est-32.1%
Q3 2025$0.61 vs $0.58 est+5.3%
Q2 2025$0.48 vs $0.45 est+6.8%
Insider activity · 90 days
10 buys15 sellsnet -33,985 shares
SAYER KEVIN RSell 26,756 · Jul 6, 2026
FOLETTA MARK GSell 199 · Jun 15, 2026
Brown Michael JonSell 1,700 · Jun 15, 2026
Recent SEC filings
4 — Insider transaction reportJul 7, 2026
4 — Insider transaction reportJun 17, 2026
4 — Insider transaction reportJun 17, 2026
Latest news
Earnings Preview: What To Expect From DexCom's Report — Yahoo · 5d ago
DexCom (NASDAQ:DXCM): An Affordable Growth Pick With Strong Momentum and Financial Health — ChartMill · 5d ago
DexCom: The Growth Thesis Still Needs To Be Proven — SeekingAlpha · 1w ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
About DexCom, Inc.
Weekly undervalued picks (like DXCM)
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.